Nairobi, Kenya – October 16, 2021: In a major milestone for the fight against cancer in Kenya, the President of the Republic of Kenya, His Excellency Uhuru Kenyatta, has inaugurated the first publicly-owned comprehensive Integrated Molecular Imaging Centre for the diagnosis and treatment of Cancer in Sub Saharan Africa. The center was built through a... Read more
Dear all our valued customers, Shimadzu Medical Systems is ready to introduce our latest products and innovative technology at the technical exhibition of RSNA2021 107th Scientific Assembly and Annual Meeting from November 28th to December 1st. In our booth there, you can find many of our advanced imaging solutions & unique applications that will provide... Read more
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting Approval is based on the Phase III IMpower010 study showing adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive Stage II-IIIA lung cancer, compared with best supportive care Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more
Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment. Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to improving patient outcomes... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 14, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its third quarter 2021 results at 6:55 a.m. (ET) on Tuesday, November 2, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more
Leader in Next-Generation Sequencing Workflow Automation Gains Agency Accreditation for Animal Health Testing SAN CARLOS, CALIF. (PRWEB) OCTOBER 14, 2021 Today, Clear Labs, a leader in providing fully automated, next-generation sequencing (NGS) platforms for turnkey diagnostics, is announcing that Clear Safety Salmonella has been approved by the National Poultry Improvement Plan (NPIP) for interim use in the detection of... Read more
Oct 14, 2021 Ragusa succeeds Hans Bishop, who will continue to serve as Advisor to the CEO through end of 2021 SAN DIEGO, Oct. 14, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ:ILMN) today announced that Bob Ragusa has been appointed as Chief Executive Officer of GRAIL, a healthcare company whose mission is focused on multi-cancer early detection,... Read more
Will provide automated protein characterization, cell imaging and cell counting technologies, along with expertise and training October 14, 2021 WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today announced it is collaborating with leading life science incubators LabCentral in Boston, Massachusetts and MBC BioLabs in San Francisco, California to provide... Read more
Targets the 10% of Global Emissions Generated by Water Use and Management RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 14, 2021– Global water technology company, Xylem (NYSE:XYL), today called on water sector leaders and organizations to join a global sustainability push to reduce greenhouse gas emissions related to water systems and water management. The encouragement comes after last... Read more
New data demonstrate ENSPRYNG’s robust and sustained longer-term efficacy in preventing relapses in people with neuromyelitis optica spectrum disorder (NMOSD) More than 70% of people treated with ENSPRYNG remained relapse-free after four years in the SAkuraStar (73%) and SAkuraSky (71%) open-label extension (OLE) studies, with a favourable safety profile ENSPRYNG is now approved in 58... Read more